Status:
COMPLETED
Evaluation of Apelin-13 and Apelin-36 in Women With Recurrent Pregnancy Loss
Lead Sponsor:
Ain Shams University
Conditions:
Recurrent Pregnancy Loss
Eligibility:
FEMALE
18-40 years
Brief Summary
Lower Apelin levels are associated with hypertensive disorders with pregnancy, yet no studies investigated its levels in recurrent pregnancy loss
Eligibility Criteria
Inclusion
- pregnant women in first trimester
- negative antiphospholipid markers
- normal karyotype
Exclusion
- multiple pregnancy
- fetal malformations
- maternal diseases
- smoking or alcohol use
- history of or risk factors for preterm labor
Key Trial Info
Start Date :
January 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2023
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT05205044
Start Date
January 23 2022
End Date
January 30 2023
Last Update
February 14 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Maternity Hospital
Cairo, Cairo/القاهرة, Egypt, 71350
2
AinShams Maternity Hospital
Cairo, Egypt, 002